These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2584670)

  • 1. Rapid development of pancreatitis following reuse of 6-mercaptopurine.
    Cappell MS; Das KM
    J Clin Gastroenterol; 1989 Dec; 11(6):679-81. PubMed ID: 2584670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease.
    Haber CJ; Meltzer SJ; Present DH; Korelitz BI
    Gastroenterology; 1986 Oct; 91(4):982-6. PubMed ID: 2427386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.
    Present DH; Meltzer SJ; Krumholz MP; Wolke A; Korelitz BI
    Ann Intern Med; 1989 Oct; 111(8):641-9. PubMed ID: 2802419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C; Théorêt Y; Latour S; Seidman G
    Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
    Gallego-Gutiérrez S; Navas-López VM; Kolorz M; Bartosova L; Lukac K; Luque-Pérez S; Núñez-Caro L; García-Galán P; Fernández-Crehuet FG; Blasco-Alonso J; Serrano-Nieto MJ; Sierra-Salinas C
    J Crohns Colitis; 2015 Aug; 9(8):676-9. PubMed ID: 25968582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.
    Warman JI; Korelitz BI; Fleisher MR; Janardhanam R
    J Clin Gastroenterol; 2003 Sep; 37(3):220-5. PubMed ID: 12960720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe myelosuppression following alopecia shortly after the initiation of 6-mercaptopurine in a patient with Crohn's disease.
    Ugajin T; Miyatani H; Demitsu T; Iwaki T; Ushimaru S; Nakashima Y; Yoshida Y
    Intern Med; 2009; 48(9):693-5. PubMed ID: 19420815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease.
    Bank L; Wright JP
    Dig Dis Sci; 1984 Apr; 29(4):357-9. PubMed ID: 6538474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercaptopurine-induced fever in a patient with Crohn's disease.
    Rehr EL; Swanson KA; Kern JA
    Ann Pharmacother; 1992; 26(7-8):907-9. PubMed ID: 1504396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.
    Lobel EZ; Korelitz BI; Vakher K; Panagopoulos G
    Dig Dis Sci; 2004 Feb; 49(2):336-8. PubMed ID: 15104380
    [No Abstract]   [Full Text] [Related]  

  • 12. 6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.
    Goldstein ES; Marion JF; Present DH
    Inflamm Bowel Dis; 2004 Mar; 10(2):79-84. PubMed ID: 15168805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology.
    Markowitz JF
    Inflamm Bowel Dis; 1998 May; 4(2):117-8; discussion 118-20. PubMed ID: 9687220
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of 6-mercaptopurine in adolescents with Crohn's disease.
    Korelitz BI; Present DH
    Gastroenterology; 1991 Nov; 101(5):1459. PubMed ID: 1936825
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
    Markowitz J; Grancher K; Kohn N; Lesser M; Daum F
    Gastroenterology; 2000 Oct; 119(4):895-902. PubMed ID: 11040176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease.
    Perrault J; Greseth JL; Tremaine WJ
    Mayo Clin Proc; 1991 May; 66(5):480-4. PubMed ID: 1674293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine.
    Heizer WD; Peterson JL
    Dig Dis Sci; 1998 Aug; 43(8):1791-3. PubMed ID: 9724170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease.
    Korelitz BI; Present DH
    Dig Dis Sci; 1985 Jan; 30(1):58-64. PubMed ID: 2856904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
    Mack DR; Young R; Kaufman SS; Ramey L; Vanderhoof JA
    J Pediatr; 1998 May; 132(5):830-5. PubMed ID: 9602195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine.
    Deutsch DE; Olson AD; Kraker S; Dickinson CJ
    J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):351-3. PubMed ID: 7608833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.